A team of Japanese researchers is developing a medication that enables tooth regrowth. The innovative drug will target individuals lacking a complete set of adult teeth due to congenital factors such as anodontia. Clinical trials are set to begin in 2024, with the aim of making the drug available by 2030. The breakthrough could impact dental treatments such as dentures or implants.
News – Masimo reports cyber incident affecting production sites – teiss
Masimo has reported a cyber incident that has impacted its production sites. The company is currently assessing the situation to understand the extent of the
